Surely if all, or most of the possibilities for NNZ-2591 are to be fully evaluated, then there is no way known that Neuren could successfully do that by going alone?
- Forums
- ASX - By Stock
- NEU
- Ann: J.P. Morgan Healthcare Conference recap
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.44%
!
$13.04

Ann: J.P. Morgan Healthcare Conference recap, page-35
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.04 |
Change
0.185(1.44%) |
Mkt cap ! $1.628B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $5.518M | 420.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 110 | $13.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.04 | 783 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 48 | 13.030 |
5 | 484 | 13.020 |
12 | 1896 | 13.010 |
9 | 4635 | 13.000 |
6 | 1730 | 12.990 |
Price($) | Vol. | No. |
---|---|---|
13.040 | 567 | 3 |
13.050 | 1245 | 12 |
13.060 | 1314 | 13 |
13.070 | 2423 | 20 |
13.080 | 1934 | 9 |
Last trade - 14.29pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online